Schedule 13G ownership disclosure

Amneal Pharmaceuticals Inc

Class A Common Stock, par value $0.01 per share · CUSIP: 03168L105

Event date: 2024-12-31

Filing-level shares
Unavailable
Percent of class
Unavailable
  • UBS Group AG

    Shares: Unavailable · Class: Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001610520-25-000006
Form type
SCHEDULE 13G/A
Filer
Amneal Pharmaceuticals, Inc.
CIK
CIK 1723128
Filed
Feb 10, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub